{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:31:45Z","timestamp":1762918305798,"version":"3.41.2"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> We aimed to assess the clinical application of noninvasive prenatal screening (NIPS) based on second-trimester ultrasonographic soft markers (USMs) in low-risk pregnant women.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Data of pregnant women between April 2015 and December 2019 were retrospectively analyzed. Pregnant women [age at expected date of confinement (EDC) of &amp;lt;35\u00a0years; low risks for trisomy 21 (T21) and trisomy 18 (T18) based on maternal serum screening; presenting second-trimester USMs (7 types)] who successfully underwent NIPS and had available follow-up information were included in our study. Cases with positive NIPS results were prenatally diagnosed. All patients were followed up for 6\u00a0months to 2\u00a0years after NIPS, and their clinical outcomes were obtained. Subgroup analyses were performed according to the different USMs.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> NIPS suggested that among a total of 10,023 cases, 37 (0.37%) were at high risk of aneuploidy, including 4 T21, 6 trisomy 13 (T13), and 27 sex chromosome abnormalities (SCA). Ten cases with aneuploidy (0.10%) were confirmed by prenatal diagnosis, consisting of two T21 and eight SCA. The eight fetuses with SCA consisted of one monosomy X, two XXY, one XXXY, one XXX, one XYY, and two mosaicisms. T21 was detected in one fetus with absent or hypoplastic nasal bone and one fetus with echogenic intracardiac focus (EICF). SCA was detected in five fetuses with EICF, two fetuses with multiple soft markers, and one fetus with echogenic bowel. The positive rate of chromosomal aneuploidy was significantly higher in fetuses with absent or hypoplastic nasal bone (6.25 vs. 0.10%, <jats:italic>p<\/jats:italic> = 0.017), echogenic bowel (3.7 vs. 0.10%, <jats:italic>p<\/jats:italic> = 0.029), and multiple soft markers (0.678 vs. 0.10%, <jats:italic>p<\/jats:italic> = 0.045) than in the total fetuses. The positive predictive values (PPVs) of NIPS in these three groups were 100%, 50%, and 100%, respectively. EICF accounted for 93.25% (9,346\/10,023) of the study population, whereas the PPV of NIPS was only 20%.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> NIPS is an advanced screening test for low-risk pregnant women. In the 10,023 pregnant women sampled, SCA were more common than autosomal trisomy, and EICF was the most frequent USM but the least predictive aneuploidy. Further aneuploidy evaluation is suggested for low-risk pregnant women whose ultrasound indicates absent or hypoplastic nasal bone, echogenic bowel, or multiple soft markers. NIPS can serve as a second-line complementary screening for these women.<\/jats:p>","DOI":"10.3389\/fgene.2021.793894","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T18:29:00Z","timestamp":1640284140000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Noninvasive Prenatal Screening Based on Second-Trimester Ultrasonographic Soft Markers in Low-Risk Pregnant Women"],"prefix":"10.3389","volume":"12","author":[{"given":"Yunyun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosha","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianlong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cechuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanfang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/uog.12364","article-title":"Meta-analysis of Second-Trimester Markers for Trisomy 21","volume":"41","author":"Agathokleous","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/aogs.12334","article-title":"Ultrasonographic Fetal Soft Markers in a Low-Risk Population: Prevalence, Association with Trisomies and Invasive Tests","volume":"93","author":"\u00c5hman","year":"2014","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"B3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.pec.2009.12.011","article-title":"Did I Really Want to Know This? Pregnant Women's Reaction to Detection of a Soft Marker during Ultrasound Screening","volume":"81","author":"\u00c5hman","year":"2010","journal-title":"Patient Educ. Couns."},{"key":"B4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/AOG.0000000000004107","article-title":"Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin Summary, Number 226","volume":"136","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1111\/jog.12379","article-title":"Fetal Echogenic Bowel in Association with Zellweger Syndrome","volume":"40","author":"Aydemir","year":"2014","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14767058.2021.1903860","article-title":"Performance of Noninvasive Prenatal Screening in Twin Pregnancies: a Retrospective Study of 5469 Twin Pregnancies","volume":"1","author":"Bai","year":"2021","journal-title":"J. Maternal-Fetal Neonatal Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/0002-9378(85)90385-0","article-title":"A Sonographic Sign for the Detection in the Second Trimester of the Fetus with Down's Syndrome","volume":"151","author":"Benacerraf","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1056\/NEJMra1705345","article-title":"Sequencing of Circulating Cell-free DNA during Pregnancy","volume":"379","author":"Bianchi","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1311037","article-title":"DNA Sequencing versus Standard Prenatal Aneuploidy Screening","volume":"370","author":"Bianchi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/s0140-6736(98)03202-4","article-title":"6-year Experience of Prenatal Diagnosis in an Unselected Population in Oxford, UK","volume":"352","author":"Boyd","year":"1998","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/pd.5638","article-title":"Outcome of Fetal Echogenic Bowel: A Systematic Review and Meta\u2010analysis","volume":"41","author":"D'Amico","year":"2021","journal-title":"Prenatal Diagn."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.1038\/s41598-019-44018-4","article-title":"Clinical Application of Noninvasive Prenatal Screening for Sex Chromosome Aneuploidies in 50,301 Pregnancies: Initial Experience in a Chinese Hospital","volume":"9","author":"Deng","year":"2019","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/aogs.13263","article-title":"Absent Fetal Nasal Bone in the Second Trimester and Risk of Abnormal Karyotype in a Prescreened Population of Chinese Women","volume":"97","author":"Du","year":"2018","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"B14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000501014","article-title":"Clinical Application of Cell-free DNA Sequencing-Based Noninvasive Prenatal Testing for Trisomies 21, 18, 13 and Sex Chromosome Aneuploidy in a Mixed-Risk Population in Iran","volume":"47","author":"Garshasbi","year":"2020","journal-title":"Fetal Diagn. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/pd.5034","article-title":"The Recurrence of Sonographic 'soft Markers': Ominous Sign or 'just' Genetics?","volume":"37","author":"Ginsberg","year":"2017","journal-title":"Prenat Diagn."},{"key":"B16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40246-019-0244-0","article-title":"Factors Affecting Cell-free DNA Fetal Fraction: Statistical Analysis of 13,661 Maternal Plasmas for Non-invasive Prenatal Screening","volume":"13","author":"Hou","year":"2019","journal-title":"Hum. Genomics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2020.10.039","article-title":"Prenatal Chromosomal Microarray Analysis in 2466 Fetuses with Ultrasonographic Soft Markers: a Prospective Cohort Study","volume":"224","author":"Hu","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/pd.1618","article-title":"Maternal Anxiety and Ultrasound Markers for Aneuploidy in a Multiethnic Population","volume":"27","author":"Lee","year":"2007","journal-title":"Prenat. Diagn."},{"key":"B19","doi-asserted-by":"publisher","first-page":"666648","DOI":"10.3389\/fgene.2021.666648","article-title":"Follow-up in Patients with Non-invasive Prenatal Screening Failures: A Reflection on the Choice of Further Prenatal Diagnosis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of Fetal DNA in Maternal Plasma and Serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/pd.3999","article-title":"Are Fetuses with Isolated Echogenic Bowel at Higher Risk for an Adverse Pregnancy Outcome? Experiences from a Tertiary Referral center","volume":"32","author":"Mailath-Pokorny","year":"2012","journal-title":"Prenat Diagn."},{"key":"B22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13104-020-05009-1","article-title":"Cell-free DNA Screening for Sex Chromosomal Aneuploidies in 9985 Pregnancies: Italian Single Experience","volume":"13","author":"Margiotti","year":"2020","journal-title":"BMC Res. Notes"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/aogs.12951","article-title":"Impact of Increased Risk for Fetal Aneuploidy on Maternal Mood: a Prospective Longitudinal Study","volume":"95","author":"Nevay","year":"2016","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA Analysis for Noninvasive Examination of Trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.7863\/jum.2001.20.6.655","article-title":"Sonographic Markers of Fetal Trisomies: Second Trimester","volume":"20","author":"Nyberg","year":"2001","journal-title":"J. Ultrasound Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2021.06.079","article-title":"Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and Management of Isolated Soft Ultrasound Markers for Aneuploidy in the Second Trimester","volume":"225","author":"Prabhu","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejogrb.2017.01.060","article-title":"Antenatal Prognostic Factor of Fetal Echogenic Bowel","volume":"212","author":"Ronin","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/uog.8831","article-title":"Practice Guidelines for Performance of the Routine Mid-trimester Fetal Ultrasound Scan","volume":"37","author":"Salomon","year":"2011","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa1408408","article-title":"Copy-number Variation and False Positive Prenatal Aneuploidy Screening Results","volume":"372","author":"Snyder","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13039-018-0397-x","article-title":"Analysis of the Accuracy of Z-Scores of Non-invasive Prenatal Testing for Fetal Trisomies 13, 18, and 21 that Employs the Ion Proton Semiconductor Sequencing Platform","volume":"11","author":"Tian","year":"2018","journal-title":"Mol. Cytogenet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.ajhg.2019.10.005","article-title":"TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands","volume":"105","author":"van der Meij","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8134","DOI":"10.1038\/s41598-018-26555-6","article-title":"Identification of Copy Number Variations Among Fetuses with Ultrasound Soft Markers Using Next-Generation Sequencing","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e3199","DOI":"10.1002\/jgm.3199","article-title":"Clinical Experience Regarding the Accuracy of NIPT in the Detection of Sex Chromosome Abnormality","volume":"22","author":"Zheng","year":"2020","journal-title":"J. Gene Med."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.793894\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T18:29:04Z","timestamp":1640284144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.793894\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":33,"alternative-id":["10.3389\/fgene.2021.793894"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.793894","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"article-number":"793894"}}